Novel avenues of drug discovery and biomarkers for diabetes mellitus. - Wikidata - wikimedia - TriplyDB

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

http://www.wikidata.org/entity/Q34552287

about

Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR Erythropoietin and diabetes mellitus FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus Erythropoietin: new directions for the nervous system Targeting disease through novel pathways of apoptosis and autophagy Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy New Insights for Oxidative Stress and Diabetes Mellitus Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.Translating cell survival and cell longevity into treatment strategies with SIRT1 Targeting cardiovascular disease with novel SIRT1 pathways.SIRT1: new avenues of discovery for disorders of oxidative stress Mammalian target of rapamycin signaling in diabetic cardiovascular disease A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade Novel directions for diabetes mellitus drug discovery Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes.SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.FoxO proteins in the nervous system.

P2860

Q26749047-6F239597-F249-4506-A9BE-E7DAC6C1C5DD Q26777878-56747C17-7C9E-4955-9A5B-C7F226B742B7 Q26800615-3095BAFC-F041-4A4D-801E-0A90A577D20E Q26828425-71C3BE69-09AD-47C5-BC84-194C45B79507 Q26864639-8B255C6D-3323-40D5-852C-A1AF1EED4711 Q27015640-1D7CC2C8-F8E1-42E9-9719-F9FEE6A1391F Q28066377-471C8C6C-9032-47F0-9F01-D6F8ADEE03B9 Q28080679-9EE18925-30D4-4796-B2AB-5D6F276657B7 Q28085715-90DF4248-7A14-49BB-A8BE-A58134B636E0 Q34429082-339DA0DB-6BA8-4D1E-92E3-6E085E7A0174 Q34887803-3594531F-74EE-4641-A792-32D7C6215FC2 Q35660308-E76E8FFD-E305-4DF0-965C-E1FC04C0DDC2 Q35661632-F5788DCE-2816-4D3D-A357-1E08E81EAC64 Q35757288-5D1D7B89-4826-4507-AFE2-730611E04860 Q36100715-B291EC30-FA42-4465-A2D8-4DF8AB100A67 Q36379761-A19BFB75-284D-4134-89E1-899CB2C978C5 Q36432388-A22078A5-638C-4A8D-B0E1-B500C6C43C06 Q36487424-31911600-9172-44D0-B351-76D9271A4E9F Q38184608-27E9FA42-0363-439D-ABF7-6FFD4469744C Q38367977-8EE19079-1C85-4A36-91BA-73A751B7416C Q42031136-4B9B81EC-63BF-43ED-830D-22AC0344A7DF Q42687323-4F0B7C4F-F8DD-47A6-8265-32C1E86989B7 Q43197576-CC49A7A8-AA12-4821-A12C-6A00036DBD91 Q51761339-6108524D-A907-4B2B-9322-616FCF230491 Q53622309-7733BE02-815B-493E-AD73-8702C468659E

P2860

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

http://www.wikidata.org/entity/Q34552287

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@ast

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@en

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@nl

type

label

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@ast

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@en

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@nl

prefLabel

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@ast

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@en

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@nl

P1433

Q34552287-3E250942-DFBF-4769-8697-37BFDAA35620

P1476

Q34552287-C4FBF731-CD82-45B1-8BAF-F0B596C84F7D

P2093

Q34552287-2D5A62A5-632C-40FB-8E5C-18CB6834194D

Q34552287-3CF1352F-7458-41D2-B0D2-4238FDC0D24E

Q34552287-87837470-1036-4CAE-BE73-86CF1A1431BB

Q34552287-EA5F8E3B-1E40-4CA1-B973-DD1F2E15DB0A

P2860

Q34552287-01195439-FC57-40E7-BD0F-06CEB99EE019

Q34552287-012CB4A2-7739-4271-8986-F3E5927B1118

Q34552287-028D7BAA-9A96-477F-B72E-C2E6928967B8

Q34552287-03D1D362-7E34-4277-AC4C-A7ED06D64D3A

Q34552287-04115C26-CEB0-466C-AC26-CD914EE685E9

Q34552287-048C33C7-ECB0-4667-9197-DABBAA3736FA

Q34552287-05332057-E019-4298-82FD-A1C0CB0433E3

Q34552287-05475D1E-4DF0-442A-B1E6-CE60ED765235

Q34552287-05C5F1A7-DE31-4D43-B923-7662E14B6371

Q34552287-05C9898C-C965-45DA-8DC9-1CC8BD574D16

P304

Q34552287-13E38DD0-960E-4C2A-A76B-8329B7E65FEF

P31

Q34552287-A57763FD-A29B-449C-B201-D161B66BA15E

P356

Q34552287-2E4691CD-6391-414C-AE90-A1C4D955C0FF

P433

Q34552287-02F9FEC2-B9A3-4ECC-9EB8-218587BFA132

P478

Q34552287-01903EAE-97E7-4842-9051-12EA11B6246B

P577

Q34552287-E7C5421A-C419-4F43-AAA3-AB49FFCB756C

P5875

Q34552287-D61CDD83-0083-4C34-8C5D-6EFEE33B4351

P698

Q34552287-3D6A60AC-F169-4CFC-98B9-DB409EF29F82

P921

Q34552287-C09779D7-5CCD-47BA-9BC1-82BDF5D14AF7

P932

Q34552287-ABF8ED39-1B80-4C99-8AB4-C6F03DD9E7D8

P356

0091270010362904

P1433

The Journal of Clinical Pharmacology

P1476

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

@en

P2093

Jinling Hou

http://www.w3.org/2001/XMLSchema#string

Kenneth Maiese

http://www.w3.org/2001/XMLSchema#string

Yan Chen Shang

http://www.w3.org/2001/XMLSchema#string

Zhao Zhong Chong

http://www.w3.org/2001/XMLSchema#string

P2860

Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors

Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells

Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes

WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase

A local mechanism mediates NAD-dependent protection of axon degeneration

Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain.

Crystal structure of human nicotinamide riboside kinase

Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5

Enzymology of NAD+ homeostasis in man.

Unified nomenclature for the winged helix/forkhead transcription factors

P304

128-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270010362904

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41894766

http://www.w3.org/2001/XMLSchema#string

P698

20220043

http://www.w3.org/2001/XMLSchema#string

P921

P932

3033756

http://www.w3.org/2001/XMLSchema#string